相关实验视频

Updated: Jan 15, 2026

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

对神经性过度活性膀的肉毒素a与安慰剂的比较有效性:一个元分析

Konstantinos Tassoudis¹, Zachos Ioannis¹, Dimitropoulos Konstatninos¹

¹University Hospital of Larissa, Larissa, Greece.

Neurourology and urodynamics

|January 14, 2026

概括

在患有神经源性脱子过活性的患者中,onabotulinumtoxin A改善了膀容量和压力等泌尿动力学参数. 然而,它稍微增加了尿路感染和保留的风险.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
神经学神经学
药理学药理学是指药理学的学科.

背景情况:

下尿道功能障碍在全球普遍存在,特别是在患有神经疾病的患者中.
神经性破坏者过度活动 (NDO) 是这些功能障碍的常见和有影响的表现.
毒素A (BTXA) 是NDO的标准治疗方法.

研究的目的:

评估Onabotulinumtoxin A在治疗神经性膀方面的疗效和安全性.
评估不同类型的阿诺毒素A剂量对治疗结果的影响.

主要方法:

一个系统的文献综述和随机,双盲,安慰剂对照试验的元分析.
包括7个RCT与1592名患者,分析尿动力学参数 (MCC,MDP) 和尿失禁 (UI) 情节.
通过不良事件 (AE) 的发生率评估安全性,特别是尿路感染 (UTI) 和尿路保留 (UR).

主要成果:

在200U和300U组中,onabotulinumtoxin A显著增加了最大囊膜容量 (MCC) 和降低了最大阻断器压力 (MDP).
没有观察到对每周尿失禁发作平均次数的显著影响.
在接受Onabotulinumtoxin A治疗的组中,发现了尿路感染和尿路保留的增加.

结论:

毒素A在改善NDO的关键泌尿动力学参数方面表现出有效性.
用onabotulinumtoxin A治疗与尿路感染和UR的风险略有增加有关.
这些发现支持Onabotulinumtoxin A作为NDO的有益治疗选择,并仔细考虑潜在的副作用.

关键词:

膀膀膀膀是一个植物 (botulinum) 是一种植物.这是神经性神经质的.过度活跃的人过度活跃.毒素毒素是一种毒素.

更多相关视频

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

相关概念视频

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...